Lv2
114 积分 2024-01-30 加入
Aggregation-Induced Emission-Armored Living Bacteriophage-DNA Nanobioconjugates for Targeting, Imaging, and Efficient Elimination of Intracellular Bacterial Infection
22天前
已完结
Improving the Editing Efficiency of CRISPR-Cas9 by Reducing the Generation of Escapers Based on the Surviving Mechanism
2个月前
已完结
Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial
2个月前
已完结
Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial
2个月前
已完结
CRISPR-Cas3-armed bacteriophages for drug-resistant bacteria
2个月前
已完结
A live, programmable microbiota therapeutic disables virulence in gut pathogens
3个月前
已关闭
“Precision‐Guided Killer” Engineered Phage for Combating Carbapenem‐Resistant Klebsiella Pneumoniae Induced Inflammatory Bowel Disease
3个月前
已完结
Utilization of the microbiome in personalized medicine
4个月前
已完结
Microbiome-based therapeutics
4个月前
已完结
Dietary fibre in gastrointestinal health and disease
4个月前
已完结
皖公网安备34019202002308
